APOBEC3B and breast carcinoma: Despite a compelling case for A3B in cancer mutagenesis (key results cited in Introduction), the overall APOBEC mutation signature in cancer cannot be explained by A3B alone, because it is still evident in breast cancers lacking the entirety of the A3B gene due to a common deletion polymorphism [56].